Gross v. FBL Financial Services, Inc.

Canadian Life Companies Split Corp. Preferred Dividend Declared

Retrieved on: 
Wednesday, August 18, 2021
GLOBE, Company, Manulife, Gross v. FBL Financial Services, Inc., Sun Life Financial, Class A share, The Company, IA Financial Group, Prospectus, Security (finance)

TORONTO, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Canadian Life Companies Split Corp. (The "Company") declares its monthly distribution of $0.05417 for each Preferred share ($0.650 annually).

Key Points: 
  • TORONTO, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Canadian Life Companies Split Corp. (The "Company") declares its monthly distribution of $0.05417 for each Preferred share ($0.650 annually).
  • Distributions are payable September 10, 2021 to shareholders on record as at August 31, 2021.
  • Since inception Class A shareholders have received a total of $7.45 per share and Preferred shareholders have received a total of $9.58 per share inclusive of this distribution, for a combined total of $17.03 per unit.
  • The Company invests in a portfolio of four publicly traded Canadian life insurance companies as follows: Great-West Lifeco Inc., Industrial Alliance Insurance & Financial Services Inc., Manulife Financial Corporation and Sun Life Financial Inc.

Miravo Healthcare™ Announces Second Quarter 2021 Results

Retrieved on: 
Monday, August 9, 2021
Amortizing loan, SK Group, Conversation, Production, CEO, Board of directors, Republic, Informal economy, MD, CPP Investment Board, Gross v. FBL Financial Services, Inc., Diclofenac, Financial statement, EBITDA, MRV, TSX, License, Conference, Prescription, IFRS, Prospectus, US, DAC, Nature, Service, Board, Company, Health insurance, Animal, Pharmaceutical industry, Credit, Music

ET

Key Points: 
  • ET
    MISSISSAUGA, ON, Aug. 9, 2021 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (TSX: MRV) (OTCQX: MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced its financial and operational results for the three and six months ended June 30, 2021.
  • Adjusted EBITDA(1) was $7.4 million, a decrease of 3% compared to $7.6 million for the three months ended June 30, 2020.
  • As at June 30, 2021, cash and cash equivalents were $27.3 million.
  • In July 2021, Nuvo Pharmaceuticals (Ireland) DAC trading as Miravo Healthcare (Miravo Ireland) entered into an exclusive license and supply agreement with SK Chemicals Co., Ltd. (SK Chemicals) for the exclusive right to commercialize Suvexxin the Republic of South Korea.

Conference Call Advisory - iA Financial Group Announces Date of 2021 Second Quarter Earnings Results

Retrieved on: 
Thursday, July 15, 2021
IA Financial Group, Service companies

QUEBEC CITY, July 15, 2021 /CNW Telbec/ -iA Financial Group (iA Financial Corporation Inc. (TSX: IAG) and Industrial Alliance Insurance and Financial Services Inc. (TSX:IAF)), will disclose its2021 second quarter earnings results on Thursday, July 29, 2021.

Key Points: 
  • QUEBEC CITY, July 15, 2021 /CNW Telbec/ -iA Financial Group (iA Financial Corporation Inc. (TSX: IAG) and Industrial Alliance Insurance and Financial Services Inc. (TSX:IAF)), will disclose its2021 second quarter earnings results on Thursday, July 29, 2021.
  • Everyone is invited to attend the conference call by dialing416-641-6712 or 1800-768-6727 (toll-free within North America) 10minutes before the start of the conference.
  • All documents related to iAFinancial Group's second quarter earnings results will be published on the Company's website at ia.ca , under About iA, in the Investor Relations/Financial Reports section, at around9:00am (ET) on Thursday, July 29, 2021.
  • iA Financial Group is a business name and trademark of iA Financial Corporation Inc. and Industrial Alliance Insurance and Financial Services Inc.